Highlights QuidelOrtho Corporation

Equities

QDEL

US2197981051

Real-time Estimate Cboe BZX Other stock markets 11:57:58 2024-04-29 am EDT			5-day change	1st Jan Change
40.83 ^USD	+3.00%		+4.40%	-44.64%

Apr. 02	QuidelOrtho Shares Fall on Decision to Withdraw FDA 510(k) Submission for Savanna RVP4+ Assay	MT
Apr. 02	QuidelOrtho Gets US FDA Clearance For QuickVue COVID-19 Test	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

QuidelOrtho Shares Fall on Decision to Withdraw FDA 510(k) Submission for Savanna RVP4+ Assay	Apr. 02	MT
QuidelOrtho Gets US FDA Clearance For QuickVue COVID-19 Test	Apr. 02	MT
QuidelOrtho Corporation Receives FDA 510(K) Clearance for its QuickVue COVID-19 Test	Apr. 02	CI
QuidelOrtho Receives Canada's Approval for Triage PLGF Test to Detect Pregnancy Complications	Mar. 06	MT
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Wednesday as Traders Recover From Inflation Figures Shock	Feb. 14	MT
QuidelOrtho Q4 Adjusted Earnings, Revenue Fall; 2024 EPS Outlook Lags; Shares Plunge Premarket	Feb. 14	MT
QuidelOrtho Q4 Adjusted Earnings, Revenue Fall; 2024 Outlook Set -- Shares Slump After Hours	Feb. 13	MT
(QDEL) QUIDELORTHO CORPORATION Sees Fiscal Year 2024 EPS Range $2.40 - $3.07	Feb. 13	MT
Earnings Flash (QDEL) QUIDELORTHO CORPORATION Posts Q4 Revenue $743M, vs. Street Est of $787.5M	Feb. 13	MT
Earnings Flash (QDEL) QUIDELORTHO CORPORATION Reports Q4 EPS $1.17, vs. Street Est of $2.06	Feb. 13	MT
Tranche Update on QuidelOrtho Corporation's Equity Buyback Plan announced on August 17, 2022.	Feb. 13	CI
QuidelOrtho Corporation Provides Earnings Guidance for the Fiscal Year 2024	Feb. 13	CI
QuidelOrtho Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 13	CI
QuidelOrtho Corporation Provides Revenue Guidance for the Year 2023	Jan. 08	CI
QuidelOrtho Corporation Receives 510(K) Clearance for Savanna(R) Multiplex Molecular Platform and Savanna(R) HSV 1+2/VZV PCR Assay	Dec. 20	CI
Tranche Update on QuidelOrtho Corporation's Equity Buyback Plan announced on August 17, 2022.	Nov. 02	CI
(QDEL) QUIDELORTHO CORPORATION Expects Fiscal Year 2023 EPS Range $4.85 - $5.30	Nov. 01	MT
Earnings Flash (QDEL) QUIDELORTHO CORPORATION Posts Q3 Revenue $744M, vs. Street Est of $692.3M	Nov. 01	MT
Earnings Flash (QDEL) QUIDELORTHO CORPORATION Reports Q3 EPS $0.90, vs. Street Est of $0.56	Nov. 01	MT
QuidelOrtho Corporation Provides Earnings Guidance for the Year 2023	Nov. 01	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights QuidelOrtho Corporation

Equities

QDEL

US2197981051

Highlights

Filters